BrandMemo | manage and share brands you love  Pharmamedix su Facebook  Pharmamedix su Twitter
 Home | News | About us | Comitato scientifico | Iscriviti | Utenti | Etica | Contenuti | Guida | Faq | Stage | Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clonazepam

Rivotril

Bibliografia - Quali fonti bibliografiche per Clonazepam?


         

1. Altshuler L.L. et al., Am. J. Psychiatry, 1996, 153 (5), 592.

2. Boghen D. et al., Can. J. Neurol. Sci., 1986, 13 (3), 245.

3. Bonate P.L. et al., J. Clin. Psychopharmacol., 2000, 20 (1), 19.

4. Bouckoms A.J., Litman R.E., Psychosomatics, 1985, 26 (12), 933.

5. Brodie M.J. et al., NEJM, 1996, 334, 168.

6. Browne T.R., NEJM, 1978, 299, 812.

7. Compendium Suisse des Medicamentes, 1994, De Lorey T.M. et al., J. Biol. Chem., 1992, 267, 167.

8. Culhane N.S, Hodle A.D, Ann. Pharmacother., 2001, 35, 874.

9. Debruyne D. et al., Therapie, 2010, 65 (3), 219.

10. Dolovich L.R. et al, BMJ, 1998, 317 (7162), 839.

11. Eriksson A.S. et al., Epilepsia, 1996, 37 (8), 769.

12. Fishbain D.A. et al., Pain Med., 2000, 1 (4), 332.

13. Fossey M.D., Hamner M.B., 1994-1995, 1 (5), 233.

14. Goodman e Gilman, Le basi farmacologiche della terapia, 1996, Ed. 9a, Edit. Zanichelli.

15. Gremeau-Richard C. et al., 2004, 108 (1-2), 51.

16. Haukkamaa M., Duodecim., 1987, 103 (9), 598.

17. Horiguchi J. et al., Jpn. J. Psychiaty Neurol., 1992, 46 (3), 727.

18. Hugel H. et al., J. Pain Symptom Manage, 2003, 26 (6), 1073.

19. Jackson C.W. et al., Ann. Clin. Psychiatry, 1995, 7 (3), 139.

20. Joy M.S., ANNA J., 1997, 24 (6), 686.

21. Kaplan S.A. et al., Ann. Rev. Pharmacol. Toxicol., 1982, 22, 245.

22. Koczerginski D. et al., Int. Clin. Psychopharmacol., 1989, 4 (3), 195.

23. Minor J.S., Epstein J.B., Otolaryngol. Clin. North Am., 2011, 44 (1), 205.

24. Oberlander T.F. et al., J. Clin. Psychiatry, 2004, 65 (2), 230.

25. Olesen J.B. et al., Pharmacoepidemiol. Drug Saf., 2010, 19 (5), 518.

26. Patton L.L. et al., Oral Surg. Oral Med. Pral pathol. Oral Radiol. Endod., 2007, 103 (suppl.), S39.e1.

27. Peiris J.B. et al., Med. J. Aust., 1976, 1 (8), 225.

28. Peled R., Lavie P., J. Neurol. Neurosurg. Psychiatry, 1987, 50 (12), 1679.

29. Reid S.D., Clin. Neuropharmacol., 2004, 27 (3), 101.

30. Seree E.J. et al., Fundam. Clin. Pharmacol., 1993, 7 (2), 69.

31. Shinno H. et al., Prog. Neuropsychopharmacol. Biol. Psychiatry., 2010, 34 (3), 522.

32. Swiader M.J., Pharmacol. Rep., 2006, 58 (1), 131.

33. Yukawa E. et al., J. Clin. Psychopharmacol., 2001, 21 (6), 588.

34. Witt D.M. et al., Ann. Pharmacother., 1993, 27 (12), 1463.